全文获取类型
收费全文 | 1865篇 |
免费 | 172篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 57篇 |
妇产科学 | 45篇 |
基础医学 | 238篇 |
口腔科学 | 42篇 |
临床医学 | 221篇 |
内科学 | 330篇 |
皮肤病学 | 44篇 |
神经病学 | 230篇 |
特种医学 | 46篇 |
外科学 | 224篇 |
综合类 | 15篇 |
预防医学 | 167篇 |
眼科学 | 26篇 |
药学 | 158篇 |
中国医学 | 1篇 |
肿瘤学 | 185篇 |
出版年
2023年 | 34篇 |
2022年 | 16篇 |
2021年 | 39篇 |
2020年 | 33篇 |
2019年 | 61篇 |
2018年 | 49篇 |
2017年 | 57篇 |
2016年 | 69篇 |
2015年 | 62篇 |
2014年 | 71篇 |
2013年 | 97篇 |
2012年 | 141篇 |
2011年 | 140篇 |
2010年 | 74篇 |
2009年 | 58篇 |
2008年 | 111篇 |
2007年 | 98篇 |
2006年 | 94篇 |
2005年 | 75篇 |
2004年 | 96篇 |
2003年 | 79篇 |
2002年 | 74篇 |
2001年 | 16篇 |
2000年 | 17篇 |
1999年 | 29篇 |
1998年 | 12篇 |
1997年 | 20篇 |
1996年 | 19篇 |
1995年 | 10篇 |
1994年 | 10篇 |
1993年 | 20篇 |
1992年 | 24篇 |
1991年 | 17篇 |
1990年 | 21篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 14篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 5篇 |
1981年 | 7篇 |
1979年 | 13篇 |
1978年 | 18篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1970年 | 5篇 |
1963年 | 5篇 |
排序方式: 共有2044条查询结果,搜索用时 234 毫秒
121.
Clausen RP Hansen KB Calí P Nielsen B Greenwood JR Begtrup M Egebjerg J Bräuner-Osborne H 《European journal of pharmacology》2004,499(1-2):35-44
We have determined the pharmacological activity of N-hydroxypyrazole analogues (3a and 4a) of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid (AMAA), as well as substituted derivatives of these two compounds. The pharmacological profile of 3a is closer to that of thioibotenic acid rather than ibotenic acid, while 4a is a selective N-methyl-D-aspartic acid (NMDA) receptor agonist. Ring substitution of 3a and 4a leads to NMDA receptor antagonists. Whereas efficacy of 3a derivatives at mglu2 receptor decreases from agonism via partial agonism to antagonism with increasing substituent size, substitution abolishes affinity for mglu1 and mglu4 receptors. Ligand- and receptor-based modelling approaches assist in explaining these pharmacological trends among the metabotropic receptors and suggest a mechanism of partial agonism at mglu2 receptor similar to that proposed for the GluR2 glutamate receptor. 相似文献
122.
Hermit MB Greenwood JR Nielsen B Bunch L Jørgensen CG Vestergaard HT Stensbøl TB Sanchez C Krogsgaard-Larsen P Madsen U Bräuner-Osborne H 《European journal of pharmacology》2004,486(3):241-250
In this study, we have determined and compared the pharmacological profiles of ibotenic acid and its isothiazole analogue thioibotenic acid at native rat ionotropic glutamate (iGlu) receptors and at recombinant rat metabotropic glutamate (mGlu) receptors expressed in mammalian cell lines. Thioibotenic acid has a distinct pharmacological profile at group III mGlu receptors compared with the closely structurally related ibotenic acid; the former is a potent (low microm) agonist, whereas the latter is inactive. By comparing the conformational energy profiles of ibotenic and thioibotenic acid with the conformations preferred by the ligands upon docking to mGlu1 and models of the other mGlu subtypes, we propose that unlike other subtypes, group III mGlu receptor binding sites require a ligand conformation at an energy level which is prohibitively expensive for ibotenic acid, but not for thioibotenic acid. These studies demonstrate how subtle differences in chemical structures can result in profound differences in pharmacological activity. 相似文献
123.
Kristiansen M Andersen B Iversen LF Westergaard N 《Journal of medicinal chemistry》2004,47(14):3537-3545
Inhibition of glycogen phosphorylase (GP) has attracted considerable attention during the last five to 10 years as a means of treating the elevated hepatic glucose production seen in patients with type 2 diabetes. Several different GP inhibitors binding to various binding sites of the GP enzyme have been reported in the literature. In this paper we report on a novel class of compounds that have been identified as potent GP inhibitors. Their synthesis, mode of binding to the allosteric AMP site as well as in vitro data on GP inhibition are shown. The most potent inhibitor was found to be 4-[2,4-bis-(3-nitrobenzoylamino)phenoxy]phthalic acid (4j) with an IC(50) value of 74 nM. This compound together with a closely related analogue was further characterized by enzyme kinetics and in primary rat hepatocytes. 相似文献
124.
Gromada J Brock B Schmitz O Rorsman P 《Basic & clinical pharmacology & toxicology》2004,95(6):252-262
Glucagon-like peptide-1 (GLP-1) is an intestinally derived insulinotropic hormone currently under investigation for use as a novel therapeutic agent in the treatment of type 2 diabetes. One of several important effects of GLP-1 is on nutrient-induced pancreatic hormone release and is mediated by binding to a specific G-protein coupled receptor resulting in the activation of adenylate cyclase and an increase in cAMP generation. In the beta-cell, cAMP binds and modulates activities of both protein kinase A and cAMP-regulated guanine nucleotide exchange factor II, thereby enhancing glucose-dependent insulin secretion. The stimulatory action of GLP-1 on insulin secretion involves interaction with a plethora of signal transduction processes including ion channel activity, intracellular Ca(2+) handling and exocytosis of the insulin-containing granules. In this review we focus principally on recent advances in our understanding on the cellular mechanisms proposed to underlie GLP-1's insulinotropic effect and attempt to incorporate this knowledge into a working model for the control of insulin secretion. Lastly, this review discusses the applicability of GLP-1 as a therapeutic agent for the treatment of type 2 diabetes. 相似文献
125.
126.
Miller DH Filippi M Fazekas F Frederiksen JL Matthews PM Montalban X Polman CH 《Annals of neurology》2004,56(2):273-278
The diagnosis of multiple sclerosis (MS) has been improved in recent decades with the incorporation of paraclinical investigations in diagnostic workup. In the last 15 years, magnetic resonance imaging (MRI) has become an especially valuable tool for supporting MS diagnosis, and specific imaging criteria became fundamental to the guidelines for the diagnosis of MS published in 2001 by an international panel (IP). The new IP criteria include MRI evidence of dissemination in space and time, making it possible to diagnose MS after a single clinical episode. This review considers current evidence concerning the reliability of the new IP criteria for the diagnosis of relapsing-onset MS, discusses strengths and weaknesses of the criteria, and outlines areas which may need modification or should be the focus of future research directed toward improving diagnostic accuracy. It also makes practical recommendations when using MRI and the IP criteria in MS diagnosis, especially in patients with clinically isolated syndromes or atypical presentations. The IP criteria are timely and concrete and introduce an important concept to MS diagnosis. Future modifications, based on emerging evidence, should further facilitate their implementation and improve their accuracy. 相似文献
127.
128.
Barfoed AM Kristensen B Dannemann-Jensen T Viuff B Bøtner A Kamstrup S Blixenkrone Møller M 《Vaccine》2004,22(11-12):1395-1405
Using the nucleoprotein of porcine reproductive and respiratory syndrome virus as model antigen, we optimised parameters for gene gun vaccination of pigs, including firing pressure and vaccination site. As criteria for optimisation, we characterised particle penetration and local tissue damage by histology. For selected combinations, vaccination efficiency in terms of antibody response was studied. Gene gun vaccination on ear alone was as efficient as a multi-site (ear, thorax, inguinal area, tongue mucosa) gene gun approach, and more efficient than combined intramuscular (i.m.)/intradermal (i.d.) injection of plasmid DNA. This indicates, that the ear is an attractive site for gene gun vaccination of pigs. 相似文献
129.
130.
Naus CW Jones FM Satti MZ Joseph S Riley EM Kimani G Mwatha JK Kariuki CH Ouma JH Kabatereine NB Vennervald BJ Dunne DW 《The Journal of infectious diseases》2003,187(8):1272-1282
We examined specific immunoglobulin G1 (IgG1) and IgG3 responses to Plasmodium falciparum schizont and Schistosoma mansoni egg and worm antigens in individuals from Kenya, Uganda, and the Sudan who had been exposed to malaria and schistosomiasis. A strong correlation between malaria- and schistosome-specific IgG3 responses was observed. This association appears to result from the presence of cross-reactive components of the 2 parasites that bind IgG3 antibodies, rather than to be mediated by immunological cross-regulation or specific regulatory mechanisms induced by either parasite. Cross-reactivity of IgG3 antibodies was confirmed in a Brazilian cohort of individuals living in an area where schistosomiasis is endemic but no malaria occurs and in a Pakistani cohort from an area where malaria is endemic but no schistosomiasis occurs. An IgG3 interaction with antigens from both parasites was observed in individuals from both cohorts, but not in uninfected European control subjects. The immunological and biological implications of this observation require further exploration. 相似文献